CD19
Cross-source consensus on CD19 from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Where it comes from
Highlighted claims
- CD19 is broadly expressed across B-lineage development but not on fully differentiated long-lived plasma cells. — Resetting autoimmune disease with CAR cell therapies
- Anti-CD19 CAR T cells deplete B cells in peripheral blood and deep tissue compartments. — Resetting autoimmune disease with CAR cell therapies
- CD19 CAR T selectively suppresses the type I interferon gene signature in SLE. — Resetting autoimmune disease with CAR cell therapies
- CD19-targeted allogeneic CAR T was applied to severe myositis and systemic sclerosis. — Resetting autoimmune disease with CAR cell therapies